市場調查報告書
商品編碼
1218793
全球耳鼻喉激光設備市場:到 2028 年的預測——按類型、便攜性、應用、最終用戶和地區分析ENT Laser Devices Market Forecasts to 2028 - Global Analysis By Type, By Portability, By Application, By End Users and Geography |
根據Stratistics MRC,2022年全球耳鼻喉激光設備市場規模將達到1.2775億美元,2028年將達到2.1109億美元,預測期內佔比8.73%,預計增長速度為的複合年增長率
術語“耳鼻喉科激光”也常用於指代 CO2 激光。 在耳鼻喉科,CO2 激光手術常用於治療耳鼻喉疾病。 該手術是一種微創手術 (MIS),時間短,副作用少,並且絕對精確地完成。 通過在心臟中植入心臟起搏器,即使是老年人也能證明其效果。 特別是在醫療保健行業,激光技術正在全球範圍內取得進展。 激光手術有很多優點,其中一些優點是微創、最小出血和無痛體驗。 這些設備還具有減少手術所需時間的重要優勢。 耳鼻喉科手術的技術發展導致耳鼻喉科激光儀器的使用增加。 不再需要輸血,因為新型激光設備減少了出血量。 這些關鍵因素導致耳鼻喉科手術中激光設備的使用增加,最終將推動市場擴張。
根據 QualSight 發布的估計,到 2019 年美國將有 2300 萬例 LASIK 視力矯正手術,近視手術佔總數的大部分。
市場動態
驅動程序
耳鼻喉科疾病患病率增加
在受耳鼻喉科疾病影響的其他重要身體部位中,耳朵、鼻子和喉嚨除了作為感覺器官外,對於維持身體的平衡感也至關重要。 由於新手術技術的發展,鼻竇炎、扁桃體炎、睡眠呼吸暫停和咽/口腔癌等耳鼻喉科疾病的住院人數正在增加。 此外,耳鼻咽喉科領域炎症性疾病的發生頻率正在增加,需要最先進的治療方法和治療設備。 在此背景下,越來越多的供應商專注於擴大其耳鼻喉激光設備陣容,這可能會刺激市場擴張。
抑製劑
耳鼻喉科手術費用高
耳鼻喉手術的高成本是市場擴張的主要障礙。 耳鼻喉手術的總費用可能高達 10,000 美元。 發展中國家的人們可能負擔不起如此昂貴的相關服務。 這些因素可能會阻礙 ENT 激光設備的普及,從而限制預測期內的增長。
機會
快速的技術改進
隨著耳鼻喉科手術技術的發展,耳鼻喉科激光設備的使用越來越頻繁。 一種新型激光設備減少了出血量,因此不再需要輸血。 整容耳鼻喉手術現在在世界各地頻繁進行,預計會顯著增長。 這些關鍵因素將增加激光儀器在耳鼻喉科手術中的使用,並最終推動市場擴張。
威脅
嚴格的規定
由於遵守與激光產品安全相關的若干規則和指南非常重要,因此不同地區有不同的規定。 此外,耳鼻喉科手術的高成本、產品召回以及管理激光設備生產和使用的嚴格法律法規可能會在預測期內限制市場擴張。
COVID-19 的影響
意想不到的 COVID-19 大流行對市場造成了嚴重破壞,並導致了廣泛的疾病和死亡。 此外,由於大流行,許多耳鼻喉科診所關閉,擇期手術(ESP)被取消,這對耳鼻喉科醫療器械的銷售造成了影響。 此外,來自中國等其他國家的原材料和製成品的進出口也受到限制。 這些限制在 2020 年初造成供需失衡,導致耳鼻喉激光設備區域市場低迷。 然而,隨著 COVID-19 病例數量的下降,封鎖已經解除,原材料的進出口已經恢復。
預計在預測期內咽和顎癌將成為最大的細分市場
在預測期內,喉癌和唇癌部分預計將佔據最大份額。 隨著咽癌和口腔癌在世界上變得越來越普遍,它們在市場上佔據主導地位。 今年美國約有 54,010 名成年患者(38,800 名男性和 15,210 名女性)被證實患有口腔和口咽癌。 癌症患者的增加是市場擴張的推動力。
預計在預測期內門診手術中心部分的複合年增長率最高
由於耳鼻喉科手術的需求,門診手術中心越來越受歡迎,預計門診手術中心部分在預測期內的複合年增長率最高。 需求是由醫療保健基礎設施的可及性、耳鼻喉手術的可負擔性以及公眾對手術成功或失敗的意識不斷增強所驅動的。 ASC 努力為患者提供最好的手術體驗,同時向政府、其他利益相關者和患者收取盡可能低的費用。
市場份額最高的地區
由於每年耳鼻喉癌患者的數量不斷增加,預計北美地區在預測期內將佔最大份額。 北美地區約佔整體市場增長的 43%。 此外,根據美國癌症協會的數據,到 2021 年,該國將新增約 12,960 例喉癌病例,導致約 3,770 人死亡。 此類事件將促進該地區的市場擴張。
複合年增長率最高的地區
在預測期內,預計亞太市場的複合年增長率最高。 亞洲耳鼻喉設備市場受到越來越多的微創耳鼻喉手術偏好、新興國家可支配收入增加、人口迅速老齡化、市場參與者越來越關注印度以及監管標準的推動。由於諸如以下因素,預計該市場將增長的鬆動
主要發展
2021 年 9 月,波士頓科學完成了對 Lumenis LTD 的收購。 從 Baring Private Equity Asia 收購手術業務。 Lumenis Surgical 業務包括用於耳鼻喉科和泌尿外科手術的實施光纖和配件以及一流的激光系統,預計到 2021 年將產生約 2 億美元的總收入。
2020 年 7 月,奧林巴斯公司推出了 SOLTIVE 超脈衝激光系統,該系統以緊湊的多功能封裝提供卓越的性能。 其 150u 光纖的總輸出功率是競爭對手較小光纖的 3 倍4。
本報告的內容
免費定制服務
訂閱此報告的客戶將免費獲得以下自定義選項之一。
According to Stratistics MRC, the Global ENT Laser Devices Market is accounted for $127.75 million in 2022 and is expected to reach $211.09 million by 2028 growing at a CAGR of 8.73% during the forecast period. The term "ENT lasers" is also frequently used to refer to CO2 lasers. In Otolaryngology, CO2 laser surgery is frequently used to treat conditions of the ear, nose, and throat. It is a minimally invasive surgery (MIS) that is completed quickly, with few side effects, and with absolute precision. By having pacemakers in their hearts, the elderly can put it into action. Particularly in the healthcare industry, laser technology has become increasingly popular on a global scale. Laser surgery has many benefits, some of which are minimal invasion, minimal bleeding, and atraumatic experience. These devices also have the important advantage of reducing the amount of time needed for surgery. The use of ENT laser equipment has increased as a result of technological developments in ENT surgery. Blood transfusions are no longer necessary because new laser device types have reduced blood loss. These important factors have led to a rise in the use of laser equipment during ENT procedures, which will ultimately fuel market expansion.
According to estimates published by QualSight, the number of LASIK vision correction procedures in the US through 2019 reached 23 million, with myopia surgeries comprising the bulk of all surgeries.
Market Dynamics:
Driver:
The increasing prevalence of ENT disorders
The ear, nose, and throat, among other important body parts affected by ENT disorders, are crucial for maintaining the body's sense of balance in addition to serving as sensory organs. Hospitalizations for ENT conditions like sinusitis, tonsillitis, sleep apnea, and throat and mouth cancer have increased as a result of the development of new surgical techniques. In addition, the increasing frequency of inflammatory disorders of the ear, nose, and throat shows the need for cutting-edge treatment methods and devices. Due to this demand, a growing number of vendors are concentrating on extending their selection of ENT laser devices, which can spur market expansion.
Restraint:
High cost for ENT surgeries
The primary factor severely impeding the expansion of this market is the higher cost of ENT procedures. An ENT procedure can cost up to USD 10,000 in total. People in developing nations might not be able to afford such expensive related services. These factors may limit the growth during the forecast period by impeding the widespread adoption of ENT laser devices.
Opportunity:
Rapid technological improvements
ENT laser devices are now being used more frequently as a result of technological developments in ENT surgery. Blood transfusions are no longer necessary because new laser device types have reduced blood loss. Cosmetic ENT surgeries are now performed frequently all over the world and are predicted to grow significantly. These important factors have led to a rise in the use of laser equipment during ENT procedures, which will ultimately fuel market expansion.
Threat:
Stringent regulations
Regulations differ from region to region because it's crucial to follow several rules and guidelines related to the security of laser products. Furthermore, the high cost of ENT procedures, product recalls, and strict laws and regulations governing the production and use of laser devices could restrain market expansion during the forecast period.
COVID-19 Impact
A unforeseen COVID-19 outbreak that resulted in significant market damage and widespread illness and death. Additionally, due to the pandemic, many ENT clinics have closed and elective surgical procedures (ESPs) have been discontinued, which has hurt the sale of ENT medical devices. Additionally, there were restrictions on the import and export of raw materials and other finished goods from other nations, such as China. These restrictions led to a supply-demand imbalance in early 2020, which is what caused the regional market for ENT laser devices to slow down. However, lockdowns have been lifted and raw material import and export have resumed as a result of the declining number of COVID-19 cases.
The Throat and Mouth Cancer segment is expected to be the largest during the forecast period
The Throat and Mouth Cancer segment is anticipated to witness largest share during the projection period. Throat and mouth cancer dominated the market because it is becoming more and more common in the world. About 54,010 adult patients (38,800 men and 15,210 women) were found to have oral and oropharyngeal cancer in the United States this year. This increase in cancer cases fuels market expansion.
The Ambulatory Surgical Centers segment is expected to have the highest CAGR during the forecast period
The market's popularity of ambulatory surgical centres has grown due to the demand for ENT procedures therefore Ambulatory Surgical Centers segment is anticipated to register highest CAGR over the forecast period. Demand is being driven by the accessibility of health infrastructure, the affordability of ENT procedures, and growing public awareness of the success or failure of procedures. ASCs strive to give patients the best surgical experience while charging the government, other parties, and patients the least amount of money.
Region with largest share:
Due to the rising number of ear, nose, and throat cancer cases each year, North America region is expected to hold largest share during the forecast period. The North America region accounts for nearly 43% of the market's overall growth. Additionally, according to the American Cancer Society, there will be nearly 12,960 new cases of laryngeal cancer in the country in 2021, contributing to about 3770 fatalities. Such occurrences fuel market expansion in the region.
Region with highest CAGR:
During the forecast period, the market in Asia Pacific is anticipated to have the highest CAGR. The Asian ENT devices market is anticipated to grow as a result of factors including a rising preference for minimally invasive ENT procedures, rising disposable income in developing nations, a rapidly increasing elderly population, increased focus on India by market players, and laxer regulatory standards.
Key players in the market
Some of the key players profiled in the ENT Laser Devices Market include IRIDEX Corp., Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Smith and Nephew plc, Sunny Optoelectronic Technology Co. Ltd, Limmer Laser GmbH, Lumenis Ltd., Olympus Corp., XIO Group, ARC Laser GmbH., Boston Scientific Corp. and El.En. S.p.a.
Key Developments:
In September 2021, Boston Scientific Corp, Closes the Acquisition of Lumenis LTD. Surgical Business from Baring Private Equity Asia. The Lumenis surgical business inculcates fibres and accessories and premier laser systems implemented for otolaryngology, and urology procedures, with total revenue expected to be around $200 million for 2021.
In July 2020, Olympus Corp launched SOLTIVE Super Pulsed Laser systems to deliver exceptional performance in a small and versatile package. Its 150u fibre can provide approximately three times the total power of competitor's small fibers4.
Types Covered:
Portability Covered:
Applications Covered:
End Users Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options: